News From Law.com

Monopoly Prices?: Big Pharma Co. Amgen Accused of Anticompet...

An antitrust class action filed in the Eastern District of Virginia accuses Amgen Inc. of preventing competition and maintaining monopoly prices with its blockbuster Enbrel prescription drug for treating adults with rheumatoid arthritis, according to the complaint filed by two nonprofit corporations doing business as CareFirst BlueCross BlueShield.

Biotech & Pharmaceuticals

August 09, 2024, 1:59 PM